Sergii V. Girin, Iryna V. Savinova, Iryna V. Antonenko, Natalia V. Naumenko

Show more
Cascade-Medical Reference Laboratory UBI, Glevakha, Ukraine.
Show less

Abstract: For today it is known, that primary and secondary disorders of the aerobic respiration, which are based on mitochondrial deficiency, lead to a wide spectrum of clinical manifestations and diseases. Therefore, the question about effective correction of various types of energy exchange disorders remains topical. Thus, the aim of our work was the study effect of the complex of biologically active substances (BAS) in ultra low concentrations on the activity of key enzymes of aerobic energy metabolism succinate dehydrogenase (EC 1.3.99.1) (SQR) and mitochondrial glycerol-3-phosphate dehydrogenase (EC 1.1.99.5) (GPD2). The human lymphocytes assays were tested in vitro (22 donors). In negative control lymphocytes, cell culture normal saline solution was added. Normal saline solution with NaN3 was added in positive control lymphocytes cell culture. Experimental cell culture contained NaN3 and BAS. Our investigations had been revealed increase SQR activity in the experimental cell culture as compared with positive control culture throughout the time of experiment (measurements were carried out at 4, 24, 48, 72 h of incubation). The SQR activity of experimental cell culture and negative control lymphocytes cell culture was equal up to 24 h of experiment. It showed neutralization of NaN3 inhibitory effect (during 24 h) due to BAS influence. Activity of base glycerophosphate shunt ferment GPD2 of experimental lymphocyte cell culture was not different from GPD2 index in the negative control, but was lower than GPD2 activity in the positive control. It also indicated neutralization NaN3 inhibitory effect due to BAS influence. So we had found that extremely low concentrations of selected BAS with their complex impact on human lymphocytes in vitro could effectively neutralize the inhibitory effect of NaN3 on processes of aerobic energy metabolism link.

Keywords: Energy Metabolism, Ultralow Concentrations, Succinate Dehydrogenase, Glycerol-3-Phosphate Dehydrogenase

Cite this paper: Girin, S. , Savinova, I. , Antonenko, I. and Naumenko, N. (2016) The Effect of Ultra Low Concentrations of Some Biologically Active Substances on the Aerobic Respiration. CellBio, 5, 1-13. doi: 10.4236/cellbio.2016.51001.

References

[1]   Sukhorukov, V.S. and Nikolaeva, E.A. (2004) Violation of the Сellular Energy Exchange in Children. Ataes Medica Soft, Moscow, 79.

[2]   Copeland, W. (2002) Mitochondrial DNA Methods and Protocols. Methods in Molecular Biology, 197, 401.

[3]   Weissig, V. and Edeas, M. (2015) Mitochondrial Medicine. Methods in Molecular Biology. Springer Science + Business Media, New York.

[4]   Gvozdjáková, A. (2008) Mitochondrial Medicine. Mitochondrial Metabolism, Diseases, Diagnosis and Therapy. Springer Science + Business Media, B.V. Dordrecht, Netherlands.

[5]   Koene, S. and Smeitink, J. (2011) Mitochondrial Medicine. Journal of Inherited Metabolic Disease, 34, 247-248.
http://dx.doi.org/10.1007/s10545-011-9292-x

[6]   Dorey, E. (2014) Mitochondrial Medicine. Nature Biotechnology, 32, 300.
http://dx.doi.org/10.1038/nbt0414-300a

[7]   Sukhorukov, V.S. (2011) Studies of Mitochondrial Pathology. Publishing House “Medpraktika-M”, Moscow, 288.

[8]   Scatena, R. (2012) Mitochondria and Drugs. Advances in Experimental Medicine and Biology, 942, 329-346.
http://dx.doi.org/10.1007/978-94-007-2869-1_15

[9]   Parikh, S., Saneto, R., Falk, M., Anselm, I., Cohen, B. and Haas, R. (2009) A Modern Approach to the Treatment of Mitochondrial Disease. Current Treatment Options in Neurology, 11, 414-430.
http://dx.doi.org/10.1007/s11940-009-0046-0

[10]   Andreazza, A. and Scola, G. (2015) Toxicology Studies—Cells, Drugs and Environment. In: Andreazza, A. and Scola, G., Eds., InTech, Rijeka, 62-63.
http://dx.doi.org/10.5772/58714

[11]   Khuda-Bukhsh, A.R. (2014) Current Trends in High Dilution Research with Particular Reference to Gene Regulatory Hypothesis. The Nucleus, 57, 1, 3-17.
http://dx.doi.org/10.1007/s13237-014-0105-0

[12]   Wälchli, C., Baumgartner, S. and Bastide, M. (2006) Effect of Low Doses and High Homeopathic Potencies in Normal and Cancerous Human Lymphocytes: An in Vitro Isopathic Study. The Journal of Alternative and Complementary Medicine, 12, 421-427.

[13]   Lenger, K., Bajpai, R. and Spielmann, M. (2014) Identification of Unknown Homeopathic Remedies by Delayed Luminescence. Cell Biochemistry and Biophysics, 68, 321-334.
http://dx.doi.org/10.1007/s12013-013-9712-7

[14]   Ezz, H. and Elkala, S. (2015) Ultra-Low-Dose Naloxone Added to Fentanyl and Lidocaine for Peribulbar Anesthesia: A Randomized Controlled Trial. Egyptian Journal of Anesthesia, 31, 161-165.
http://dx.doi.org/10.1016/j.egja.2014.12.005

[15]   Yovell, Y., Bar, G., Mashiah, M., Baruch, Y. and Briskman, I. (2015) Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial. The American Journal of Psychiatry, 15, 231-241
http://dx.doi.org/10.1176/appi.ajp.2015.15040535

[16]   Thompson, T. and Weiss, M. (2006) Homeopathy—What Are the Active Ingredients? An Exploratory Study Using the UK Medical Research Council’s Framework for the Evaluation of Complex Interventions. BMC Complementary and Alternative Medicine, 12, 6-37.
http://dx.doi.org/10.1186/1472-6882-6-37

[17]   Winchester, R.J. and Ross, G. (1976) Methods for Enumerating Lymphocyte Populations in Manual of Clinical Immunology. In: Rose, N.R. and Friedman, H., Eds., American Society for Microbiology, Washington DC, 64-76.

[18]   Burlakova, E.B., Conrad, A.A. and Maltseva, E.L. (2003) Ultralow Doses Action of Biologically Active Substances and Low-Intensity Physical Factors. Chemical Physics, 22, 21-40.

[19]   Yagoda, A.V. and Lokteva, N.A. (2005) Clinical Cytochemistry. SiGMA, Stavropol, 485.

[20]   Lapach, S.N., Chubenko, A.V. and Babich, P.N. (2001) Statistical Methods in Biomedical Research Using Excel. 2nd Edition, MORION, Kyiv, 196.